Upgrade to SI Premium - Free Trial

BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $62 at RBC Capital

July 7, 2026 7:59 AM
RBC Capital analyst Luca Issi lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change